Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-mlys
/
Mineralys Therapeutics Inc
MLYS
Add to Watchlist
26.890
USD
-0.090
-0.33%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
26.980
USD
+26.980
After-hours 07/02, 17:00 (ET)
2.37B
Market Cap
Loss
P/E TTM
Mineralys Therapeutics Inc
26.890
-0.090
-0.33%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Catalys Pacific, LLC
9.58%
RA Capital Management, LP
9.33%
Samsara BioCapital, LLC
7.12%
Fidelity Management & Research Company LLC
5.11%
BlackRock Institutional Trust Company, N.A.
4.57%
Other
64.30%
Shareholders
Shareholders
Proportion
Catalys Pacific, LLC
9.58%
RA Capital Management, LP
9.33%
Samsara BioCapital, LLC
7.12%
Fidelity Management & Research Company LLC
5.11%
BlackRock Institutional Trust Company, N.A.
4.57%
Other
64.30%
Shareholder Types
Shareholders
Proportion
Investment Advisor
31.74%
Venture Capital
28.42%
Hedge Fund
24.05%
Investment Advisor/Hedge Fund
22.28%
Private Equity
3.13%
Research Firm
3.11%
Pension Fund
1.02%
Sovereign Wealth Fund
0.79%
Individual Investor
0.72%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
406
98.38M
119.25%
+2.95M
2025Q4
357
89.95M
113.65%
+10.64M
2025Q3
315
76.75M
101.61%
+1.04M
2025Q2
287
68.74M
105.48%
+8.03M
2025Q1
278
68.91M
105.92%
+7.50M
2024Q4
230
53.93M
108.22%
-5.12M
2024Q3
214
51.53M
103.61%
-6.38M
2024Q2
197
51.29M
104.21%
-4.08M
2024Q1
188
49.20M
100.04%
-4.93M
2023Q4
172
42.00M
101.88%
-1.03M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Catalys Pacific, LLC
8.90M
11.25%
--
--
Sep 30, 2025
RA Capital Management, LP
7.32M
9.25%
+1.18M
+19.14%
Sep 30, 2025
Samsara BioCapital, LLC
6.26M
7.91%
+588.24K
+10.37%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.02M
2.55%
+1.72M
+562.93%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.19M
4.03%
+455.45K
+16.65%
Sep 30, 2025
State Street Investment Management (US)
1.30M
1.65%
-140.54K
-9.74%
Sep 30, 2025
Caligan Partners, LP
2.77M
3.5%
+755.30K
+37.44%
Sep 30, 2025
HBM Partners AG
2.25M
2.84%
--
--
Sep 30, 2024
Franklin Advisers, Inc.
1.81M
2.28%
+5.87K
+0.33%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Simplify Health Care ETF
7.48%
Invesco Dorsey Wright Healthcare Momentum ETF
2.35%
Virtus LifeSci Biotech Clinical Trials ETF
1.85%
Invesco Dorsey Wright SmallCap Momentum ETF
0.58%
Tema Heart & Health ETF
0.53%
State Street SPDR S&P Biotech ETF
0.32%
iShares Micro-Cap ETF
0.31%
ProShares Ultra Nasdaq Biotechnology
0.27%
Invesco Nasdaq Biotechnology ETF
0.27%
Optimize Strategy Index ETF
0.26%
View more
Simplify Health Care ETF
Proportion
7.48%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
2.35%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1.85%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.58%
Tema Heart & Health ETF
Proportion
0.53%
State Street SPDR S&P Biotech ETF
Proportion
0.32%
iShares Micro-Cap ETF
Proportion
0.31%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.27%
Invesco Nasdaq Biotechnology ETF
Proportion
0.27%
Optimize Strategy Index ETF
Proportion
0.26%